A Double-blinded, Randomized, Placebo-controlled, Parallel-group Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection (UTI) in Adult Women Recently Treated for UTI.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03366077|
Recruitment Status : Recruiting
First Posted : December 8, 2017
Last Update Posted : March 2, 2018
Urinary tract infections (UTIs) are the most common bacterial infections in women, with about 50% of women experiencing at least one UTI in their lifetime.
The main pharmacological treatments of cystitis usually involve the use of antibiotics, in particular quinolones (such as ciprofloxacin and levofloxacin), fosfomycin, second-generation and third-generation cephalosporins, and b-lactam antibiotics associated with b-lactamase inhibitors.
|Condition or disease||Intervention/treatment||Phase|
|Recurrent Urinary Tract Infection (UTI) in Adult Women Recently Treated for UTI||Dietary Supplement: Probiotic||Not Applicable|
This is a double-blinded, randomized, placebo-controlled, parallel-group study evaluating the effect of the probiotic on recurrent urinary tract infection (UTI) in adult women recently treated for UTI.
Primary objective The primary objective is to evaluate the effect of oral supplementation with probiotic on the frequency of UTI during six months from start of intervention in adult women with recurrent UTI.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||140 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||double-blinded, randomized, placebo-controlled, parallel-group|
|Official Title:||A Double-blinded, Randomized, Placebo-controlled, Parallel-group Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection (UTI) in Adult Women Recently Treated for UTI.|
|Actual Study Start Date :||December 15, 2017|
|Estimated Primary Completion Date :||December 31, 2019|
|Estimated Study Completion Date :||December 31, 2019|
|Active Comparator: Active||
Dietary Supplement: Probiotic
|Placebo Comparator: Placebo||
Dietary Supplement: Probiotic
- Mean number of confirmed UTIs during six months from start of intervention, as compared to placebo [ Time Frame: 6 M ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03366077
|Clinical Trial Consultants AB||Recruiting|
|Uppsala, Sweden, 752 37|
|Contact: erik Rein-Hedin, MD +46 768 339 888 email@example.com|
|Contact: Anna Stendahl, PhD +46 768 339 888 firstname.lastname@example.org|